Product Title:Â Recent Developments in Beta-blockers Research
Format:
PDF,
Overview (Details, Topics and Speakers):
by
Â
This book highlights recent advances in beta blockers research. Beta blockers have been used for the treatment of several clinical conditions and it is of paramount importance to understand their role and applications. Chapters of the book were written by experts in the fields of vascular disease, plastic surgery, cardiovascular medicine, pharmaceutical medicine and physiology from various countries such as the United States, the United Kingdom, Brazil, Japan and New Zealand.
Clinical topics on recent advances in â-blockers research covered in this book include the clinical effectiveness of â-blockers in patients with peripheral arterial disease, abdominal aortic aneurysm, heart failure, acute coronary syndrome, pulmonary hypertension, object memory recognition, portal hypertension and infantile hemangioma. These chapters were written by authors who are experts in their fields and by researchers who are most up-to-date in the recent literature on advances in â-blockers research.
This book would be of great value for researchers in the field of â-blockers and adds up-to-date knowledge on the use of this class of drugs in several diseases. It will certainly contribute additional, valuable knowledge to what is already known about this very important class of drugs. This book is also a valuable source of information for residents and medical students to help enable them to keep abreast with recent evidence concerning beta blockers. (Imprint: Nova Biomedical)
Â
Product Details
- Hardcover: 125 pages
- Publisher: Nova Science Pub Inc (May 20, 2015)
- Language: English
- ISBN-10: 1634824091
- ISBN-13: 978-1634824095
Delivery Method
the Recent Developments in Beta-blockers Research course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at [email protected] or fill in the form below:
Reviews
There are no reviews yet.